Amy Kang

Nephrologist and PhD student

[Amy Kang @AmyKang23]

Risk factors for #COVID19 in #kidney #transplant recipients. Vaccination reduced risk of COVID19 and death. Presented by Daniela Potter. #ANZSNASM @UNSW @westernsydneyu

[Amy Kang @AmyKang23]

The @reducction trial in #haemodialysis, showed that step-tip vascular catheters have a higher risk of dysfunction than symmetrical tip catheters. Really interesting talk by Ben Lazarus. #ANZSNASM @SradhaKotwal @kidneybloke @georgeinstitute @MonashUni

[Amy Kang @AmyKang23]

Interesting talks by Mary Ann Nicdao showing great clinical outcomes with incremental #peritoneal #dialysis from Western Sydney renal. @Sydney_Uni #ANZSNASM

[Amy Kang @AmyKang23]

People with end-stage #kidney disease have a high burden of symptoms, poor #mobility and poor #QoL that worsens over time. Provocative talk by @ThaiBinhTran4. #ANZSNASM @Sydney_Uni @UNSW @DrRiaArnold

[Amy Kang @AmyKang23]

#CTLA4-Ig but not bortezomib treated an animal model of #membranous nephropathy. An interesting talk by @EdmundChung. @Sydney_Uni #ANZSNASM

[Amy Kang @AmyKang23]

A wonderful talk by @brendonneuen at young investigator awards. #SGLT2i are safe and effective at reducing kidney failure in people with diabetic kidney disease on diuretics. #CREDENCE trial #ANZSNASM @georgeinstitute @UNSW @VladoPerkovic @jardine_meg

[Amy Kang @AmyKang23]

Excellent talk by Ben Lazarus on @reducction trial. A multi-faceted intervention can reduce catheter dysfunction events by 1/3. Patient factors are important. Young investigator award at #ANZSNASM @dialysisbloke @SradhaKotwal @kidneybloke @georgeinstitute

[Amy Kang @AmyKang23]

Dessert for nephrologists at #ANZSNASM 2022

[Amy Kang @AmyKang23]

Impressive results from #testing trial presented by @danakim67 at the young investigator award. Reduced dose methylprednisone reduces #kidney failure or death due to kidney disease in #IgAN but with higher risk of infection. #ANZSNASM @georgeinstitute @Sydney_Uni @UNSW @muhgeot

[Amy Kang @AmyKang23]

An impressive talk by @GeorginaIrish using a model to predict who will gain #survival and/or #QoL (quality of life) benefit with a #kidney #transplant compared to those on the waitlist on dialysis. Young Investigator Awards at #ANZSNASM @ANZDATARegistry

[Amy Kang @AmyKang23]

#Machine learning might do the #renal pathologist's job for them! 😳 interesting algorithms from @Dchristiadi85 #ANZSNASM

[Amy Kang @AmyKang23]

In people receiving #haemodialysis , we can predict who will have a high flow #fistula but the relationship between fistula flow and heart failure is complex! #flowmatters Great talk by @nasir_a_shah. #ANZSNASM @UNSW

[Amy Kang @AmyKang23]

#Kidney transplant recipients given Sotrovimab for #COVID19 in the Christmas wave had great survival but 1 out of 3 had persistent symptoms after 3 months. Interesting data presented by Daniel Hirsch #ANZSNASM

[Amy Kang @AmyKang23]

A fantastic talk by @neeru_agarwal88. The SWIFT pilot suggests that caring about #PROMS and QoL can improve QoL in people on HD. #ANZSNASM @TrialsCentre @jardine_meg @brendanjsmyth

[Amy Kang @AmyKang23]

@CJASN @JNNP_BMJ @VladoPerkovic @camusfallen @jardine_meg Also @DrRiaArnold @brendanjsmyth @kidneybloke @CarmelHawley @dr_krisdr

[ASN Publications @asnpublications]

Neuropathy is a common complication of kidney disease that lacks proven disease-modifying treatments. This study found that hemodiafiltration did not affect neuropathy progression https://t.co/aLN2YTshqg

@JNNP_BMJ @VladoPerkovic @AmyKang23 @camusfallen @jardine_meg

[Amy Kang @AmyKang23]

@georgeinstitute @SradhaKotwal @TheRACP @RobynNorton8 @ISNkidneycare @vjha126 @Badves @VladoPerkovic @jardine_meg @carinnahockham @ncdalliance @womeninGH @Kidney_Int Congratulations!

[Nature Reviews Nephrology @NatRevNeph]

In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibitors beyond T2DM https://t.co/2P2TIJ3OoU

[Sydney Clinical Trials Centre @TrialsCentre]

2020 has been an impressive year for #SGLT2 inhibitors! We now know SGLT2 inhibitors improve #kidney and #heart failure outcomes in people without diabetes. Check out our Year in Review by @amykang23 @jardine_meg in @natrevneph. Full text in https://t.co/zzcEDp635w.

[Amy Kang @AmyKang23]

Wow what an impressive and inspiring talk by @angelacwebster, recipient of the TJ Neale award, on her life and career!!! #2020ANZSN @TrialsCentre